Ferda Bilgir

473 total citations
34 papers, 338 citations indexed

About

Ferda Bilgir is a scholar working on Hematology, Pathology and Forensic Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ferda Bilgir has authored 34 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Pathology and Forensic Medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ferda Bilgir's work include Growth Hormone and Insulin-like Growth Factors (4 papers), Thyroid Disorders and Treatments (4 papers) and Platelet Disorders and Treatments (4 papers). Ferda Bilgir is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (4 papers), Thyroid Disorders and Treatments (4 papers) and Platelet Disorders and Treatments (4 papers). Ferda Bilgir collaborates with scholars based in Türkiye, United Kingdom and France. Ferda Bilgir's co-authors include Oktay Bilgir, Mehmet Çalan, Levent Kebapçılar, Giray Bozkaya, Arif Yüksel, Özlem Gürsoy Çalan, Yaşar Yıldız, İ̇smail Sarı, Cengiz Kırmaz and Hülya Çolak and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of the Medical Sciences and International Journal of Clinical Practice.

In The Last Decade

Ferda Bilgir

32 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ferda Bilgir Türkiye 11 76 72 60 49 44 34 338
Heidi Robertshaw United Kingdom 9 38 0.5× 69 1.0× 49 0.8× 94 1.9× 17 0.4× 17 336
Davide Rosati Italy 12 77 1.0× 33 0.5× 14 0.2× 99 2.0× 60 1.4× 37 361
Shogo Imagawa Japan 10 45 0.6× 32 0.4× 33 0.6× 55 1.1× 13 0.3× 24 314
Eujin Park South Korea 14 52 0.7× 23 0.3× 40 0.7× 47 1.0× 56 1.3× 61 575
Pernille M. Hansen Denmark 12 24 0.3× 152 2.1× 60 1.0× 82 1.7× 24 0.5× 19 402
Blaise Robin France 13 84 1.1× 128 1.8× 37 0.6× 87 1.8× 102 2.3× 25 571
Leonard A. Arbeit United States 13 35 0.5× 42 0.6× 56 0.9× 55 1.1× 28 0.6× 19 551
Omar Saeed United States 8 56 0.7× 54 0.8× 161 2.7× 70 1.4× 17 0.4× 15 531
Anggoro Budi Hartopo Indonesia 12 32 0.4× 27 0.4× 53 0.9× 60 1.2× 10 0.2× 72 450

Countries citing papers authored by Ferda Bilgir

Since Specialization
Citations

This map shows the geographic impact of Ferda Bilgir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferda Bilgir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferda Bilgir more than expected).

Fields of papers citing papers by Ferda Bilgir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferda Bilgir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferda Bilgir. The network helps show where Ferda Bilgir may publish in the future.

Co-authorship network of co-authors of Ferda Bilgir

This figure shows the co-authorship network connecting the top 25 collaborators of Ferda Bilgir. A scholar is included among the top collaborators of Ferda Bilgir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferda Bilgir. Ferda Bilgir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bilgir, Ferda, et al.. (2024). Epiregulin: A new prognostic molecule in non-Hodgkin lymphoma. Irish Journal of Medical Science (1971 -). 193(3). 1201–1207.
3.
Bilgir, Ferda, et al.. (2021). Roles of certain biochemical and hematological parameters in predicting mortality and ICU admission in COVID-19 patients. Revista da Associação Médica Brasileira. 67(suppl 1). 67–73. 6 indexed citations
4.
Bilgir, Ferda, et al.. (2019). Clinical Features of Patients with Chronic Urticaria and the Results of the Skin Prick Tests. 17(2). 91–96. 1 indexed citations
5.
Aksun, Saliha, Ferda Bilgir, İlker Burak Arslan, et al.. (2018). Allergic Rhinitis and Its Relationship with IL-10, IL-17, TGF-β, IFN-γ, IL 22, and IL-35. Disease Markers. 2018. 1–6. 48 indexed citations
6.
Bilgir, Oktay, et al.. (2018). Relationship between insulin resistance, hs-CRP, and body fat and serum osteoprotegerin/RANKL in prediabetic patients. Minerva Endocrinology. 43(1). 19–26. 13 indexed citations
7.
Bilgir, Oktay, Ferda Bilgir, Mehmet Çalan, et al.. (2017). Relationship Between Serum Macrophage Migration Inhibitory Factor Level and Insulin Resistance, High-Sensitivity C-Reactive Protein and Visceral Fat Mass in Prediabetes. The American Journal of the Medical Sciences. 355(1). 37–43. 3 indexed citations
8.
Yüksel, Arif, Ferda Bilgir, Oktay Bilgir, Mehmet Çalan, & Giray Bozkaya. (2015). Increased circulating macrophage migration inhibitory factor levels are associated with coronary artery disease. Clinics. 70(3). 169–172. 8 indexed citations
9.
Bilgir, Oktay, Ferda Bilgir, Mehmet Çalan, Özlem Gürsoy Çalan, & Arif Yüksel. (2015). Comparison of pre- and post-levothyroxine high-sensitivity c-reactive protein and fetuin-a levels in subclinical hypothyroidism. Clinics. 70(2). 97–101. 36 indexed citations
10.
Bilgir, Oktay, Ferda Bilgir, Giray Bozkaya, & Mehmet Çalan. (2013). Changes in the levels of endothelium-derived coagulation parameters in nonalcoholic fatty liver disease. Blood Coagulation & Fibrinolysis. 25(2). 151–155. 17 indexed citations
11.
12.
Bilgir, Oktay, et al.. (2013). An experience with plasma exhcange treatment of acute lymphoblastic leukemia in a case with fulminant hepatitis related to l-asparaginase. Transfusion and Apheresis Science. 49(2). 328–330. 4 indexed citations
13.
Bilgir, Oktay, Ferda Bilgir, Levent Kebapçılar, et al.. (2011). Comparison of conventional dose steroid treatment and high dose steroid treatment as run-in regime for splenectomy in immune thrombocytopenic purpura (ITP). Transfusion and Apheresis Science. 44(3). 239–242. 4 indexed citations
14.
15.
Bilgir, Ferda, et al.. (2011). Soluble CD40 ligand, high sensitive C-reactive protein and fetuin-A levels in patients with essential thrombocythemia. Transfusion and Apheresis Science. 46(1). 67–71. 3 indexed citations
16.
Gülhan, İbrahim, Giray Bozkaya, Ferda Bilgir, et al.. (2010). Serum homocysteine and asymmetric dimethylarginine levels in patients with premature ovarian failure: a prospective controlled study. Gynecological Endocrinology. 27(8). 568–571. 3 indexed citations
17.
18.
Bilgir, Oktay, et al.. (2009). Is there any relationship between imatinib mesylate medication and hypothalamic-pituitary-adrenal axis dysfunction?. International Journal of Clinical Practice. 64(1). 45–50. 22 indexed citations
19.
Kebapçılar, Levent, Oktay Bilgir, İnci Alacacıoğlu, et al.. (2009). Does Imatinib Mesylate Therapy Cause Growth Hormone Deficiency?. Medical Principles and Practice. 18(5). 360–363. 15 indexed citations
20.
Bilgir, Oktay, et al.. (2008). Immunoadsorption method using immunoglobulin Adsopak in adult cases with ITP resistant to splenectomy and other medical therapies. Transfusion and Apheresis Science. 39(2). 109–113. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heidi Robertshaw Breakdown of academic impact, for papers by Davide Rosati Breakdown of academic impact, for papers by Shogo Imagawa Breakdown of academic impact, for papers by Eujin Park Breakdown of academic impact, for papers by Pernille M. Hansen Breakdown of academic impact, for papers by Blaise Robin Breakdown of academic impact, for papers by Leonard A. Arbeit Breakdown of academic impact, for papers by Omar Saeed Breakdown of academic impact, for papers by Anggoro Budi Hartopo
Rankless by CCL
2026